Repligen to Report First Quarter 2024 Financial Results
WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first […]
Labrador Gold Files NI43-101 Technical Report for the Kingsway Project
TORONTO, April 17, 2024 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“LabGold” or the “Company”) […]
SL Green and Vornado Announce 280 Park Avenue Mortgage Loan Refinancing
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG) and Vornado Realty Trust (NYSE: VNO) […]
SL Green and Vornado Announce 280 Park Avenue Mezzanine Loan Repayment
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG) and Vornado Realty Trust (NYSE: VNO) […]
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease – – ATH434-201 Phase 2 […]
O-I Glass Sustainably Transformed and Expanded Zipaquira, Colombia, Plant
Significant advances in sustainability, flexibility and productivity Investment of approximately $120 Million Approximately 100 new jobs in the region PERRYSBURG, […]
POET Augments Investor Outreach Efforts and Announces Management Role Change
TORONTO, April 17, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the […]
Gilat to Report First Quarter 2024 Results on May 8th
PETAH TIKVA, Israel, April 17, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader […]
Brink’s Schedules First-Quarter 2024 Earnings Release and Conference Call for May 8, 2024
RICHMOND, Va., April 17, 2024 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables […]
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally. BPL-003 was shown to be […]
